Page last updated: 2024-10-31

nafamostat and Carditis

nafamostat has been researched along with Carditis in 2 studies

nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic

Research Excerpts

ExcerptRelevanceReference
"However, she died of multiple organ failure and systemic cytomegalovirus infection in the chronic stage."1.32[Fulminant myocarditis treated with percutaneous cardiopulmonary support and long-term complications: three case reports]. ( Kusaba, T; Matsumuro, A; Nakahara, Y; Nakamura, T; Sawada, S, 2004)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kusaba, T1
Nakahara, Y1
Matsumuro, A1
Nakamura, T1
Sawada, S1
Morishima, I1
Sassa, H1
Sone, T1
Tsuboi, H1
Kondo, J1
Koyama, T1

Other Studies

2 other studies available for nafamostat and Carditis

ArticleYear
[Fulminant myocarditis treated with percutaneous cardiopulmonary support and long-term complications: three case reports].
    Journal of cardiology, 2004, Volume: 43, Issue:4

    Topics: Acute Disease; Adolescent; Adult; Aged; Anticoagulants; Benzamidines; Cardiopulmonary Bypass; Fatal

2004
A case of fulminant myocarditis rescued--by long-term percutaneous cardiopulmonary support.
    Japanese circulation journal, 1994, Volume: 58, Issue:6

    Topics: Acute Disease; Adult; Antithrombins; Benzamidines; Complement Inactivator Proteins; Guanidines; Hear

1994